These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29226142)

  • 1. Computational Exploration for Lead Compounds That Can Reverse the Nuclear Morphology in Progeria.
    Rampogu S; Baek A; Son M; Zeb A; Park C; Kumar R; Lee G; Kim D; Choi Y; Cho Y; Park Y; Park SJ; Lee KW
    Biomed Res Int; 2017; 2017():5270940. PubMed ID: 29226142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulations.
    Rampogu S; Baek A; Zeb A; Lee KW
    BMC Cancer; 2018 Mar; 18(1):264. PubMed ID: 29514608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Lonafarnib-Like Compounds: Pharmacophore Modeling and Molecular Dynamics Studies.
    Rampogu S; Baek A; Son M; Park C; Yoon S; Parate S; Lee KW
    ACS Omega; 2020 Feb; 5(4):1773-1781. PubMed ID: 32039312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore modeling, virtual screening, molecular docking studies and density functional theory approaches to identify novel ketohexokinase (KHK) inhibitors.
    Kavitha R; Karunagaran S; Chandrabose SS; Lee KW; Meganathan C
    Biosystems; 2015 Dec; 138():39-52. PubMed ID: 26521124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lonafarnib for cancer and progeria.
    Wong NS; Morse MA
    Expert Opin Investig Drugs; 2012 Jul; 21(7):1043-55. PubMed ID: 22620979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting natural compounds against HER2 kinase domain as potential anticancer drugs applying pharmacophore based molecular modelling approaches.
    Rampogu S; Son M; Baek A; Park C; Rana RM; Zeb A; Parameswaran S; Lee KW
    Comput Biol Chem; 2018 Jun; 74():327-338. PubMed ID: 29702367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome.
    Gordon LB; Kleinman ME; Miller DT; Neuberg DS; Giobbie-Hurder A; Gerhard-Herman M; Smoot LB; Gordon CM; Cleveland R; Snyder BD; Fligor B; Bishop WR; Statkevich P; Regen A; Sonis A; Riley S; Ploski C; Correia A; Quinn N; Ullrich NJ; Nazarian A; Liang MG; Huh SY; Schwartzman A; Kieran MW
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16666-71. PubMed ID: 23012407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonanilide Derivatives in Identifying Novel Aromatase Inhibitors by Applying Docking, Virtual Screening, and MD Simulations Studies.
    Rampogu S; Son M; Park C; Kim HH; Suh JK; Lee KW
    Biomed Res Int; 2017; 2017():2105610. PubMed ID: 29312992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farnesyltransferase inhibitors: a comprehensive review based on quantitative structural analysis.
    Moorthy NS; Sousa SF; Ramos MJ; Fernandes PA
    Curr Med Chem; 2013; 20(38):4888-923. PubMed ID: 24059235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Novel Scaffolds with Dual Role as Antiepileptic and Anti-Breast Cancer.
    Rampogu S; Baek A; Bavi R; Son M; Cao GP; Kumar R; Park C; Zeb A; Rana RM; Park SJ; Lee KW
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(5):1663-1674. PubMed ID: 30334765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discover potential inhibitors for PFKFB3 using 3D-QSAR, virtual screening, molecular docking and molecular dynamics simulation.
    Bao Y; Zhou L; Dai D; Zhu X; Hu Y; Qiu Y
    J Recept Signal Transduct Res; 2018; 38(5-6):413-431. PubMed ID: 30822195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria.
    Fong LG; Frost D; Meta M; Qiao X; Yang SH; Coffinier C; Young SG
    Science; 2006 Mar; 311(5767):1621-3. PubMed ID: 16484451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicine. Drug trial offers uncertain start in race to save children with progeria.
    Couzin-Frankel J
    Science; 2012 Sep; 337(6102):1594-5. PubMed ID: 23019622
    [No Abstract]   [Full Text] [Related]  

  • 14. Progeria: case report and new drugs perspectives.
    Grana AG; Silva AA; Moura Filho FR; Rodrigues Ferreira Rocha de Alencar R; Chicre Bandeira de Melo P
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e293-e294. PubMed ID: 29377371
    [No Abstract]   [Full Text] [Related]  

  • 15. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of Novel Inhibitors for Bruton's Tyrosine Kinase by 3D QSAR Modeling and Molecular Dynamics Simulation.
    Bavi R; Kumar R; Choi L; Woo Lee K
    PLoS One; 2016; 11(1):e0147190. PubMed ID: 26784025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation.
    Wu M; Han J; Liu Z; Zhang Y; Huang C; Li J; Li Z
    Life Sci; 2020 Oct; 258():118228. PubMed ID: 32781071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential HIV-1 integrase strand transfer inhibitors: in silico virtual screening and QM/MM docking studies.
    Reddy KK; Singh SK; Tripathi SK; Selvaraj C
    SAR QSAR Environ Res; 2013; 24(7):581-95. PubMed ID: 23521430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore-based virtual screening and density functional theory approach to identifying novel butyrylcholinesterase inhibitors.
    Sakkiah S; Lee KW
    Acta Pharmacol Sin; 2012 Jul; 33(7):964-78. PubMed ID: 22684028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lonafarnib: First Approval.
    Dhillon S
    Drugs; 2021 Feb; 81(2):283-289. PubMed ID: 33590450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.